AV 1101
Latest Information Update: 06 Feb 2017
At a glance
- Originator A-Viral ASA
- Developer A-Viral NL BV
- Class Anti-inflammatories; Antirheumatics; Antivirals; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections; Inflammation; Rheumatoid arthritis; Skin disorders
Most Recent Events
- 06 Feb 2017 Discontinued - Phase-II for HIV infections treatment in Philippines (unspecified route)
- 06 Feb 2017 Discontinued - Phase-II for Inflammation in Netherlands (unspecified route)
- 06 Feb 2017 Discontinued - Phase-II for Rheumatoid arthritis in Netherlands (unspecified route)